Adma Biologics (ADMA) Raw Materials (2016 - 2025)

Adma Biologics' Raw Materials history runs 10 years deep, the most recent figure standing at $96.6 million for Q4 2025.

• Quarterly Raw Materials rose 59.76% year-over-year to $96.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $96.6 million (up 59.76% YoY) and the FY2025 annual result came in at $96.6 million, up 59.76% from the prior year.
• Raw Materials was $96.6 million for Q4 2025 at Adma Biologics, up from $87.8 million in the prior quarter.
• Across five years, Raw Materials topped out at $100.4 million in Q2 2025 and bottomed at $33.1 million in Q2 2021.
• A 5-year average of $57.4 million and a median of $53.0 million in 2023 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2023 — Raw Materials gained 4.35% — and 2025, when it jumped 76.14%.
• Adma Biologics' Raw Materials stood at $36.8 million in 2021, then soared by 32.34% to $48.6 million in 2022, then increased by 8.95% to $53.0 million in 2023, then rose by 14.1% to $60.5 million in 2024, then jumped by 59.76% to $96.6 million in 2025.
• Business Quant data shows ADMA's Raw Materials at $96.6 million in Q4 2025, $87.8 million in Q3 2025, and $100.4 million in Q2 2025.